The molecular functions of RIT1 and its contribution to human disease.

RIT1 is a member of the Ras family of GTPases that direct broad cellular physiological responses through tightly controlled signaling networks. The canonical Ras GTPases are well-defined regulators of the RAF/MEK/ERK pathway and mutations in these are pathogenic in cancer and a class of developmental disorders termed RASopathies. Emerging clinical evidences have now demonstrated a role for RIT1 in RASopathies, namely Noonan syndrome, and various cancers including lung adenocarcinoma and myeloid malignancies. While RIT1 has been mostly described in the context of neuronal differentiation and survival, the mechanisms underlying aberrant RIT1-mediated signaling remain elusive. Here, we will review efforts undertaken to characterize the biochemical and functional properties of the RIT1 GTPase at the molecular, cellular, and organismal level, as well as provide a phenotypic overview of different human conditions caused by RIT1 mutations. Deeper understanding of RIT1 biological function and insight to its pathogenic mechanisms are imperative to developing effective therapeutic interventions for patients with RIT1-mutant Noonan syndrome and cancer.

[1]  K. Boyer,et al.  Complicated ventricular arrhythmia and hematologic myeloproliferative disorder in RIT1‐associated Noonan syndrome: Expanding the phenotype and review of the literature , 2020, Molecular genetics & genomic medicine.

[2]  A. Khalil,et al.  RIT1: A Novel Biomarker in Glioblastoma , 2020, bioRxiv.

[3]  Hongyan Chen,et al.  LZTR1 inactivation promotes MAPK/ ERK pathway activation in glioblastoma by stabilizing oncoprotein RIT1 , 2020 .

[4]  Jinjun Li,et al.  HIF-1α-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib. , 2019, Cancer letters.

[5]  Clint L. Miller,et al.  iPSC-Derived Cardiomyocytes Reveal Aberrant ERK5 and MEK1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome. , 2019, Circulation.

[6]  B. Gelb,et al.  Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition. , 2019, Journal of the American College of Cardiology.

[7]  P. Bork,et al.  Interactive Tree Of Life (iTOL) v4: recent updates and new developments , 2019, Nucleic Acids Res..

[8]  Y. Matsubara,et al.  New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis , 2019, EBioMedicine.

[9]  F. McCormick,et al.  RIT1 oncoproteins escape LZTR1-mediated proteolysis , 2019, Science.

[10]  S. Jamuar,et al.  The spectrum of genetic variants and phenotypic features of Southeast Asian patients with Noonan syndrome , 2019, Molecular genetics & genomic medicine.

[11]  Jian Wang,et al.  Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort , 2019, Orphanet Journal of Rare Diseases.

[12]  F. Wang,et al.  RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis , 2018, Cell Death & Disease.

[13]  L. Petrucelli,et al.  Converging pathways in neurodegeneration, from genetics to mechanisms , 2018, Nature Neuroscience.

[14]  G. Rosenberger,et al.  RIT1 controls actin dynamics via complex formation with RAC1/CDC42 and PAK1 , 2018, PLoS genetics.

[15]  Frank McCormick,et al.  RAS Proteins and Their Regulators in Human Disease , 2017, Cell.

[16]  S. Mir,et al.  IGF-1 mediated Neurogenesis Involves a Novel RIT1/Akt/Sox2 Cascade , 2017, Scientific Reports.

[17]  P. Croisille,et al.  Expanding the cardiac spectrum of Noonan syndrome with RIT1 variant: Left main coronary artery atresia causing sudden death. , 2017, European journal of medical genetics.

[18]  B. Neel,et al.  Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome , 2017, Nature Communications.

[19]  S. Mir,et al.  RIT1 GTPase Regulates Sox2 Transcriptional Activity and Hippocampal Neurogenesis* , 2016, The Journal of Biological Chemistry.

[20]  R. Martín-Fernández,et al.  RIT1: un nuevo gen causal del síndrome de Noonan , 2016 .

[21]  I. Arroyo-Carrera,et al.  [RIT1: a novel gene associated with Noonan syndrome]. , 2016, Revista de neurología (Ed. impresa).

[22]  M. Digilio,et al.  Congenital heart defects in Noonan syndrome and RIT1 mutation , 2016, Genetics in Medicine.

[23]  T. Rinne,et al.  Two cases of RIT1 associated Noonan syndrome: Further delineation of the clinical phenotype and review of the literature , 2016, American journal of medical genetics. Part A.

[24]  M. Ikura,et al.  Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1)* , 2016, The Journal of Biological Chemistry.

[25]  D. Mitter,et al.  Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation , 2016, Genetics in Medicine.

[26]  A. Křepelová,et al.  A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation—a review of the literature , 2016, European Journal of Pediatrics.

[27]  I. Mihalek,et al.  Mutations in RIT1 cause Noonan syndrome – additional functional evidence and expanding the clinical phenotype , 2016, Clinical genetics.

[28]  O. Migita,et al.  Spectrum of mutations and genotype–phenotype analysis in Noonan syndrome patients with RIT1 mutations , 2016, Human Genetics.

[29]  H. Cavé,et al.  Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia , 2016, European Journal of Human Genetics.

[30]  K. Hlinkova,et al.  New Mutations Associated with Rasopathies in a Central European Population and Genotype–Phenotype Correlations , 2016, Annals of human genetics.

[31]  Y. Teng,et al.  Elevated expression of RIT1 correlates with poor prognosis in endometrial cancer. , 2015, International journal of clinical and experimental pathology.

[32]  S. Mansour,et al.  The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome , 2015, European Journal of Human Genetics.

[33]  Yong Zhou,et al.  Ras nanoclusters: Versatile lipid-based signaling platforms. , 2015, Biochimica et biophysica acta.

[34]  Weikang Cai,et al.  mTORC2 Is Required for Rit-Mediated Oxidative Stress Resistance , 2014, PloS one.

[35]  M. Passos-Bueno,et al.  Further evidence of the importance of RIT1 in Noonan syndrome , 2014, American journal of medical genetics. Part A.

[36]  Manuel Desco,et al.  K-RasV14I recapitulates Noonan syndrome in mice , 2014, Proceedings of the National Academy of Sciences.

[37]  E. Obersztyn,et al.  Contribution of RIT1 mutations to the pathogenesis of Noonan syndrome: Four new cases and further evidence of heterogeneity , 2014, American journal of medical genetics. Part A.

[38]  John D McPherson,et al.  Next-generation sequencing identifies rare variants associated with Noonan syndrome , 2014, Proceedings of the National Academy of Sciences.

[39]  J. L. Costa,et al.  Comprehensive massive parallel DNA sequencing strategy for the genetic diagnosis of the neuro-cardio-facio-cutaneous syndromes , 2014, European Journal of Human Genetics.

[40]  J Wala,et al.  Oncogenic RIT1 mutations in lung adenocarcinoma , 2014, Oncogene.

[41]  G. Shi,et al.  Rit subfamily small GTPases: regulators in neuronal differentiation and survival. , 2013, Cellular signalling.

[42]  Toshihiko Ogura,et al.  Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. , 2013, American journal of human genetics.

[43]  G. Stamp,et al.  RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms , 2013, Cell.

[44]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[45]  Solomon H. Snyder,et al.  Erratum: Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death (Science Signaling (2013) 6: 273 (er1) Doi: 10.1126/scisignal.6273er1) , 2013 .

[46]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[47]  J. Allanson,et al.  Noonan syndrome , 2013, The Lancet.

[48]  S. Miyano,et al.  Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies , 2013, Leukemia.

[49]  C. Moncman,et al.  Rit GTPase Signaling Promotes Immature Hippocampal Neuronal Survival , 2012, The Journal of Neuroscience.

[50]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[51]  D. Higgins,et al.  Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.

[52]  Weikang Cai,et al.  An evolutionarily conserved Rit GTPase–p38 MAPK signaling pathway mediates oxidative stress resistance , 2011, Molecular biology of the cell.

[53]  P. Rosenberg,et al.  Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes , 2011, American journal of medical genetics. Part C, Seminars in medical genetics.

[54]  G. Shi,et al.  A Rit GTPase-p38 Mitogen-Activated Protein Kinase Survival Pathway Confers Resistance to Cellular Stress , 2011, Molecular and Cellular Biology.

[55]  B. Neel,et al.  MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. , 2011, The Journal of clinical investigation.

[56]  A. Fernández-Medarde,et al.  Ras in cancer and developmental diseases. , 2011, Genes & cancer.

[57]  J. Allanson,et al.  Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines , 2010, Pediatrics.

[58]  C. Der,et al.  Ras history , 2010, Small GTPases.

[59]  G. Shi,et al.  Src-dependent TrkA Transactivation Is Required for Pituitary Adenylate Cyclase-activating Polypeptide 38-mediated Rit Activation and Neuronal Differentiation , 2010, Molecular biology of the cell.

[60]  Gabriele Gillessen-Kaesbach,et al.  Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation , 2010, Human mutation.

[61]  C. H. Conrad,et al.  Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates. , 2009, Comparative medicine.

[62]  G. Shi,et al.  Rit signaling contributes to interferon‐γ‐induced dendritic retraction via p38 mitogen‐activated protein kinase activation , 2008, Journal of neurochemistry.

[63]  A. Fields,et al.  Rit mutants confirm role of MEK/ERK signaling in neuronal differentiation and reveal novel Par6 interaction. , 2007, Biochimica et biophysica acta.

[64]  M. Merchant,et al.  Hsp27 Regulates Akt Activation and Polymorphonuclear Leukocyte Apoptosis by Scaffolding MK2 to Akt Signal Complex* , 2007, Journal of Biological Chemistry.

[65]  G. Shi,et al.  The Novel GTPase Rit Differentially Regulates Axonal and Dendritic Growth , 2007, The Journal of Neuroscience.

[66]  H. Niu,et al.  MAPK-activated Protein Kinase-2 (MK2)-mediated Formation and Phosphorylation-regulated Dissociation of the Signal Complex Consisting of p38, MK2, Akt, and Hsp27* , 2006, Journal of Biological Chemistry.

[67]  T. Meyer,et al.  PI(3,4,5)P3 and PI(4,5)P2 Lipids Target Proteins with Polybasic Clusters to the Plasma Membrane , 2006, Science.

[68]  G. Shi,et al.  A Novel Cyclic AMP-Dependent Epac-Rit Signaling Pathway Contributes to PACAP38-Mediated Neuronal Differentiation , 2006, Molecular and Cellular Biology.

[69]  T. Yoshimori,et al.  Small GTPase Proteins Rin and Rit Bind to PAR6 GTP-dependently and Regulate Cell Transformation* , 2005, Journal of Biological Chemistry.

[70]  C. Montell,et al.  Activated RIC, a small GTPase, genetically interacts with the Ras pathway and calmodulin during Drosophila development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.

[71]  G. Shi,et al.  Rit Contributes to Nerve Growth Factor-Induced Neuronal Differentiation via Activation of B-Raf-Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades , 2005, Molecular and Cellular Biology.

[72]  D. Gilliland,et al.  Mouse model of Noonan syndrome reveals cell type– and gene dosage–dependent effects of Ptpn11 mutation , 2004, Nature Medicine.

[73]  J. Klein,et al.  Heat Shock Protein 27 Controls Apoptosis by Regulating Akt Activation* , 2003, Journal of Biological Chemistry.

[74]  Wei Liu,et al.  [Amplification of RIT1 in hepatocellular carcinoma and its clinical significance]. , 2003, Ai zheng = Aizheng = Chinese journal of cancer.

[75]  D. Andres,et al.  Rit promotes MEK-independent neurite branching in human neuroblastoma cells , 2003, Journal of Cell Science.

[76]  D. Andres,et al.  Induction of Neurite Extension and Survival in Pheochromocytoma Cells by the Rit GTPase* , 2002, The Journal of Biological Chemistry.

[77]  J. Gutkind,et al.  Potent transforming activity of the small GTP‐binding protein Rit in NIH 3T3 cells: evidence for a role of a p38γ‐dependent signaling pathway , 2002, FEBS letters.

[78]  Theresa M. Grana,et al.  Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways , 2000, Oncogene.

[79]  D. Andres,et al.  Biochemical characterization of the Ras-related GTPases Rit and Rin. , 1999, Archives of biochemistry and biophysics.

[80]  C. Montell,et al.  RIC, a calmodulin‐binding Ras‐like GTPase. , 1996, The EMBO journal.

[81]  D. Zack,et al.  Rin, a Neuron-Specific and Calmodulin-Binding Small G-Protein, and Rit Define a Novel Subfamily of Ras Proteins , 1996, The Journal of Neuroscience.

[82]  G. Rubin,et al.  Signalling by the sevenless protein tyrosine kinase is mimicked by Rasl activation , 1992, Nature.

[83]  Frank McCormick,et al.  The GTPase superfamily: conserved structure and molecular mechanism , 1991, Nature.

[84]  W. Kabsch,et al.  Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation , 1989, Nature.

[85]  A. Roberts,et al.  iPSC-Derived Cardiomyocytes Reveal Aberrant ERK5 and MEK1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome. , 2019, Circulation.

[86]  Jacqueline Cherfils,et al.  Regulation of small GTPases by GEFs, GAPs, and GDIs. , 2013, Physiological reviews.

[87]  S. Shvartsman,et al.  RASopathies: unraveling mechanisms with animal models , 2015, Disease Models & Mechanisms.

[88]  W. Williams,et al.  Survival implications: hypertrophic cardiomyopathy in Noonan syndrome. , 2011, Congenital heart disease.

[89]  D. Kültz,et al.  Molecular and evolutionary basis of the cellular stress response. , 2005, Annual review of physiology.

[90]  Jiahuai Han,et al.  Activation and signaling of the p38 MAP kinase pathway , 2005, Cell Research.

[91]  P. Hawkins,et al.  Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. , 2000, Cell.

[92]  G M Rubin,et al.  Ectopic expression of activated Ras1 induces hyperplastic growth and increased cell death in Drosophila imaginal tissues. , 1998, Development.

[93]  G D'Hont,et al.  [The Noonan syndrome]. , 1982, Acta oto-rhino-laryngologica Belgica.